<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g) of
the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under
Sections 13 and 15(d) of the Securities Exchange Act of 1934
Commission File Number 0-21972
INNOVIR LABORATORIES
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
2751 CENTERVILLE ROAD, SUITE 210,
LITTLE FALLS II, WILMINGTON, DE 19808,(302) 998-1734
- --------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Common Stock, $.013 par value per share
- --------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
- --------------------------------------------------------------------------------
(Title of all other classes of securities for which a duty to file reports under
Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s)
relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [_]
Rule 12g-4(a)(1)(ii) [_] Rule 12h-3(b)(2)(i) [_]
Rule 12g-4(a)(2)(i) [_] Rule 12h-3(b)(2)(ii) [_]
Rule 12g-4(a)(2)(ii) [_] Rule 15d-6 [_]
Rule 12h-3(b)(1)(i) [_]
Approximate number of holders of record as of the certification or notice
date: 83
Pursuant to the requirements of the Securities Exchange Act of 1934, Innovir
Laboratories as the successor by merger to the registrant has caused his
certification/notice to be signed on its behalf by the undersigned duly
authorized person.
DATE: /s/ March 29, 1999 By: /s/ Francis M. O'Connell
---------------------- ---------------------------
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant shall file with the Commission three copies of Form 15, one of which
shall be manually signed. It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person. The name and title of the person
signing the form shall be typed or printed under the signature.
